Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Revvity (Group)

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionising what’s possible in healthcare, with specialised focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.  With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. *


Period Start 2023-03-09 renamed
Region Region Waltham, MA
  Country United States (USA)
  Street 940 Winter Street
  City 02451 Waltham, MA
    Address record changed: 2023-07-19
Basic data Employees H: 10,001 to 50,00 (2023-07-13)
  Currency USD
  Annual sales 3,000,000,000 (revenue, annual, consolidated (2022) 2022-12-31)
    * Document for »About Section«: Revvity, Inc.. (7/13/23). "Press Release: Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge". Cambridge.
Record changed: 2023-07-19


Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

More documents for Revvity (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top